Form 4 for EW Edwards Lifesciences
Accepted 2024-11-05 00:00:00 ET · period of report 2024-11-05 · accession 0001225208-24-009655 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-05 | 2024-11-05 | EW | Wood Larry L | Gbl Pres TAVR, Surg | S - Sale | $65.91 | -25.0K | 198.5K | -11% | -$1.65M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-05 | S | D | 25,000 | $65.91 | 198,525.74 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $65.54 to $66.27. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |